| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 23.21 | -0.22 (-0.94%) | 20.18 - 27.87 | 153.2 thousand (Above Avg) |
Market data as of 3:59PM 05/24/13. Quotes are delayed by at least 15 min.
Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical Trials With Vortioxetine, An Investigational Compound For Major Depressive Disorder
05/18/2013 12:00 PM ET
Takeda Pharmaceutical Company Limited Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Fiscal Year Ending March 31, 2014
05/09/2013 2:08 AM ET
Takeda to Acquire Inviragen, Inc.
05/07/2013 7:00 PM ET